⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,710.34
+0.25%
Nasdaq 100
29,503.69
−0.09%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.46
−0.29%
NYSE:TSM
$425.30
+1.21%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,122.52
−0.44%
Brent
$108.99
−0.21%
BTC
$82,466.11
+0.76%
ETH
$2,434.04
+1.20%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,710.34
+0.25%
Nasdaq 100
29,503.69
−0.09%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$216.46
−0.29%
NYSE:TSM
$425.30
+1.21%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,122.52
−0.44%
Brent
$108.99
−0.21%
BTC
$82,466.11
+0.76%
ETH
$2,434.04
+1.20%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
BridgeBio Pharma Inc · News · TradingHolo
Markets
›
United States
› NAS
› BBIO
B
BridgeBio Pharma Inc
NAS:BBIO
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
$67.64
−0.44%
Live
In session · ≈
AED 248.41
· Market cap
$13.22B
· Next earnings
Wed 28 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
BBIO news
Headlines tagged to this company
GL
Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening
globenewswire · 27 d ago
GL
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire · 32 d ago
BE
BridgeBio Dwarfism Data Shows Broad Health Benefits Beyond Height Gain
benzinga · 41 d ago
GL
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
globenewswire · 42 d ago
GL
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
globenewswire · 42 d ago
GL
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
globenewswire · 48 d ago
GL
BBOT to Participate in Upcoming Investor Healthcare Conferences
globenewswire · 49 d ago
GL
BridgeBio to Participate in September Investor Conferences
globenewswire · 49 d ago
GL
BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
globenewswire · 50 d ago
TH
BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.
The Motley Fool · 67 d ago
GL
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
GlobeNewsWire · 68 d ago
GL
BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
GlobeNewsWire · 68 d ago
ZA
BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge
Zacks Investment Research · 70 d ago
SE
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months
Seeking Alpha · 70 d ago
SE
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
Seeking Alpha · 71 d ago
ZA
BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research · 71 d ago
MA
BridgeBio Pharma Q2 Earnings Call Highlights
MarketBeat · 71 d ago
GL
BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET
GlobeNewsWire · 79 d ago
← Previous
End of the feed